Crude | P values | Model 1 | P values | Model 2 | P values | Model 1a | P values | Model 2a | P values | |
---|---|---|---|---|---|---|---|---|---|---|
SUA | 0.17 (0.15, 0.20) | < 0.01 | 0.16 (0.13, 0.18) | < 0.01 | 0.14 (0.08, 0.20) | < 0.01 | 0.16 (0.14, 0.19) | < 0.01 | 0.14 (0.12, 0.17) | < 0.01 |
Male | 0.14 (0.10, 0.17) | < 0.01 | 0.13 (0.10, 0.17) | < 0.01 | 0.08 (–0.01, 0.16) | 0.06 | 0.14 (0.10, 0.17) | < 0.01 | 0.12 (0.09, 0.16) | < 0.01 |
Female | 0.22 (0.18, 0.25) | < 0.01 | 0.18 (0.15, 0.22) | < 0.01 | 0.22 (0.13, 0.31) | < 0.01 | 0.19 (0.16, 0.23) | < 0.01 | 0.17 (0.14, 0.20) | < 0.01 |
Hyperuricemia | 29.18 (24.36, 34.00) | < 0.01 | 27.57 (22.46, 32.67) | < 0.01 | 24.02 (11.09, 36.96) | < 0.01 | 27.27(22.84, 32.56) | < 0.01 | 23.60(19.30, 28.86) | < 0.01 |
Male | 24.77 (18.08, 31.46) | < 0.01 | 25.74 (18.70, 32.78) | < 0.01 | 15.64 (–2.98, 34.26) | 0.09 | 24.67(18.73, 32.51) | < 0.01 | 22.19(16.42, 29.99) | < 0.01 |
Female | 34.66 (27.70, 41.61) | < 0.01 | 29.11 (21.57, 36.64) | < 0.01 | 32.72 (13.08, 52.35) | < 0.01 | 30.07(23.72, 38.12) | < 0.01 | 25.20(18.96, 33.50) | < 0.01 |